Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Instil Bio, Inc. (TIL)

6.80 -0.19 (-2.71%)
As of 11:38:10 AM EST. Market Open.
Chart Range Bar
Loading chart for TIL
  • Previous Close 6.99
  • Open 6.72
  • Bid 6.88 x 100
  • Ask 7.00 x 100
  • Day's Range 6.30 - 6.96
  • 52 Week Range 5.56 - 16.00
  • Volume 39,310
  • Avg. Volume 28,885
  • Market Cap (intraday) 46.117M
  • Beta (5Y Monthly) 1.96
  • PE Ratio (TTM) --
  • EPS (TTM) -4.43
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 7.00

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

instilbio.com

17

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TIL
38.18%
S&P 500 (^GSPC)
8.46%

1-Year Return

TIL
54.73%
S&P 500 (^GSPC)
10.48%

3-Year Return

TIL
9.33%
S&P 500 (^GSPC)
70.05%

5-Year Return

TIL
98.44%
S&P 500 (^GSPC)
58.05%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
-5M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

7.00
7.00 Average
6.80 Current
7.00 High

Latest Rating

Date 1/7/2026
Analyst HC Wainwright & Co.
Rating Action Downgrade
Rating Neutral
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -10.77%

  • Return on Equity (ttm)

    -25.33%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -30.28M

  • Diluted EPS (ttm)

    -4.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    69.68M

  • Total Debt/Equity (mrq)

    81.41%

  • Levered Free Cash Flow (ttm)

    81.81M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: